14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ATRC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for AtriCure stock price on Friday moving between $20.78 and $23.01
(Updated on May 03, 2024)

Sell candidate since May 02, 2024 Loss -5.99% PDF

The AtriCure stock price fell by -5.99% on the last day (Friday, 3rd May 2024) from $22.22 to $20.89. During the last trading day the stock fluctuated 10.74% from a day low at $20.78 to a day high of $23.01. The price has been going up and down for this period, and there has been a -9.96% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 959 thousand shares were bought and sold for approximately $20.03 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -33.73% during the next 3 months and, with a 90% probability hold a price between $12.45 and $18.62 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ATRC Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The AtriCure stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $23.02 and $26.08. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, March 05, 2024, and so far it has fallen -44.71%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for AtriCure stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.23 between high and low, or 10.74%. For the last week, the stock has had daily average volatility of 9.17%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ATRC) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect AtriCure to open at $21.56, and during the day (based on 14 day Average True Range), to move between $19.40 and $22.38, which gives a possible trading interval of +/-$1.49 (+/-7.15%) up or down from last closing price. If AtriCure takes out the full calculated possible swing range there will be an estimated 14.31% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $22.22, some $1.33 (6.37%) from the current price of $20.89, our system finds the risk reward not very attractive.

Is AtriCure stock A Buy?

AtriCure holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.295 Strong Sell Candidate Unchanged

Predicted Opening Price for AtriCure of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$21.56 ( 3.21%) $20.89

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ATRC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 23.79 13.90 %
R2 22.94 9.82 %
R1 22.41 7.29 %
Current price: 20.89
Support S1 20.71 -0.87 %
S2 20.18 -3.39 %
S3 19.33 -7.48 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 24.76 18.53 %
R2 23.17 10.91 %
R1 22.22 6.37 %
Current price 20.89
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for AtriCure Stock and on which exchange is it traded?
The symbol for AtriCure is ATRC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell AtriCure Stock?
AtriCure holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy AtriCure Stock?
AtriCure Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AtriCure Stock.

What's the current price of AtriCure Stock?
As of the end of day on the May 03, 2024, the price of an AtriCure (ATRC) share was $20.89.

What is the 52-week high and low for AtriCure Stock?
The 52-week high for AtriCure Stock is $59.61 and the 52-week low is $20.19.

What is the market capitalization of AtriCure Stock?
As of the May 03, 2024, the market capitalization of AtriCure is 1.011B.

When is the next earnings date for AtriCure?
The upcoming earnings date for AtriCure is Jul 23, 2024.
Click to get the best stock tips daily for free!

About AtriCure

AtriCure AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform tem... ATRC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT